A 28-year-old man with bipolar I disorder and a history of two suicide attempts is currently in a depressive episode with suicidal ideation. He has failed trials of sertraline and citalopram. Which agent is the drug of choice to reduce his suicide risk while treating the depressive episode?

Explanation

## Lithium in Bipolar Depression with Suicide Risk **Key Point:** In bipolar depression with suicidal ideation, lithium is the gold standard because it combines mood stabilization, antidepressant efficacy, and proven suicide mortality reduction—the only agent with all three properties. **High-Yield:** Lithium is the ONLY mood stabilizer with robust evidence for reducing suicide mortality in bipolar disorder (80–90% reduction). Other anticonvulsants (valproate, lamotrigine) lack this evidence. **Clinical Pearl:** The patient's history of SSRI failure (sertraline, citalopram) is a key clinical clue. SSRIs are often ineffective in bipolar depression and may trigger mood instability. Lithium addresses both the depression and the suicidal risk simultaneously. ### Comparison of Mood Stabilizers in Bipolar Depression + Suicidality | Agent | Antidepressant Effect | Anti-suicidal Evidence | Use in Bipolar Depression | |-------|----------------------|------------------------|---------------------------| | **Lithium** | Moderate–strong | Level 1 (RCTs) | First-line monotherapy | | **Valproate** | Minimal | Level 3 (observational) | Adjunct; no suicide mortality reduction | | **Lamotrigine** | Moderate (bipolar depression) | Level 3 (limited) | Adjunct; better for maintenance | | **Quetiapine** | Moderate (at high doses) | Level 2–3 (indirect) | Adjunct; useful for acute agitation | **Warning:** Lamotrigine is effective for bipolar depression maintenance but has NO proven suicide mortality reduction and is not first-line in acute suicidal presentations. Valproate is a mood stabilizer but lacks antidepressant properties and anti-suicidal evidence. **Mnemonic:** **Li-SAVES** — **Li**thium is the only agent that **S**tabilizes mood, **A**llays **V**iolence/suicidality, **E**ffectively treats **S**uicidal bipolar patients. ### Why Lithium Here 1. **Proven suicide reduction:** 80–90% mortality reduction in bipolar disorder (only agent with this evidence) 2. **Antidepressant effect:** Effective in bipolar depression (unlike valproate) 3. **SSRI failure context:** Lithium is the natural next step when SSRIs fail in bipolar depression 4. **Dual action:** Treats depression AND reduces impulsivity/suicidality ### Dosing in This Case - **Serum level target:** 0.8–1.2 mEq/L (higher end for acute suicidality) - **Baseline labs:** Renal function, TSH, ECG - **Monitoring:** Lithium level at day 5, then weekly until stable [cite:Kaplan & Sadock's Synopsis of Psychiatry 11e Ch 29; American Psychiatric Association Practice Guideline for Mood Disorders 2015]